Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Transient cardiac effects in a child with acute cholinergic syndrome due to rivastigmine poisoning.

Raucci U, Vanacore N, Cecchetti C, Russo MS, Rossi R, Pirozzi N.

J Emerg Med. 2014 Jul;47(1):21-5. doi: 10.1016/j.jemermed.2013.11.078. Epub 2014 Feb 8.

PMID:
24518556
2.

Use of pralidoxime without atropine in rivastigmine (carbamate) toxicity.

Hoffman RS, Manini AF, Russell-Haders AL, Felberbaum M, Mercurio-Zappala M.

Hum Exp Toxicol. 2009 Sep;28(9):599-602. doi: 10.1177/0960327109107044. Epub 2009 Sep 15.

PMID:
19755437
3.

Poisoning with rivastigmine.

Brvar M, Mozina M, Bunc M.

Clin Toxicol (Phila). 2005;43(7):891-2. No abstract available.

PMID:
16440521
4.
5.

A fatal outcome after unintentional overdosing of rivastigmine patches.

Lövborg H, Jönsson AK, Hägg S.

Curr Drug Saf. 2012 Feb;7(1):30-2.

PMID:
22663954
6.

[Etiology of initially unexplained confusion of excitability in deadly nightshade poisoning with suicidal intent. Symptoms, differential diagnosis, toxicology and physostigmine therapy of anticholinergic syndrome].

Heindl S, Binder C, Desel H, Matthies U, Lojewski I, Bandelow B, Kahl GF, Chemnitius JM.

Dtsch Med Wochenschr. 2000 Nov 10;125(45):1361-5. German.

PMID:
11109424
7.

Management of acute childhood poisonings caused by selected insecticides and herbicides.

Mortensen ML.

Pediatr Clin North Am. 1986 Apr;33(2):421-45. Review.

PMID:
3515303
8.

[Electrophysiological aspects of intermediate syndrome in organophosphate poisonings].

Rafai MA, Boulaajaj FZ, Charra B, Benslama A, Motaouakkil S, Slassi I.

Rev Neurol (Paris). 2007 Apr;163(4):480-2. French.

PMID:
17452951
9.

Orphenadrine poisoning in a child: clinical and analytical data.

Van Herreweghe I, Mertens K, Maes V, Ramet J.

Intensive Care Med. 1999 Oct;25(10):1134-6.

PMID:
10551971
10.

Intensive care management of organophosphate insecticide poisoning.

Sungur M, Güven M.

Crit Care. 2001 Aug;5(4):211-5. Epub 2001 May 31.

11.

Methylphenidate poisoning: an evidence-based consensus guideline for out-of-hospital management.

Scharman EJ, Erdman AR, Cobaugh DJ, Olson KR, Woolf AD, Caravati EM, Chyka PA, Booze LL, Manoguerra AS, Nelson LS, Christianson G, Troutman WG; American Association of Poison Control Centers..

Clin Toxicol (Phila). 2007 Oct-Nov;45(7):737-52.

PMID:
18058301
12.

Cholinergic symptoms with low serum cholinesterase from therapeutic cholinesterase inhibitor toxicity.

Leikin JB, Braund V, DesLauris C.

Am J Emerg Med. 2014 Jul;32(7):815.e3-4. doi: 10.1016/j.ajem.2013.12.048. Epub 2014 Jan 3.

PMID:
24589024
13.

The First Use of Pralidoxime in a Child With Rivastigmine Poisoning.

Saz EU, Yurtseven A, Kilinç MA, Sari Y, Ağin H.

Pediatr Emerg Care. 2017 Mar 21. doi: 10.1097/PEC.0000000000001086. [Epub ahead of print]

PMID:
28328690
15.

Cholinesterase inhibitors for Parkinson's disease dementia.

Maidment I, Fox C, Boustani M.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004747. Review.

PMID:
16437494
16.

Fluoxetine and the serotonin syndrome.

Ruiz F.

Ann Emerg Med. 1994 Nov;24(5):983-5.

PMID:
7978579
17.

Cholinesterase inhibitors for Alzheimer's disease.

Birks J.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005593. Review.

18.

The tolerability and safety of cholinesterase inhibitors in the treatment of dementia.

Inglis F.

Int J Clin Pract Suppl. 2002 Jun;(127):45-63. Review.

PMID:
12139367
19.

[Carbamate and organophosphate poisoning].

Peduto VA, D'Uva R, Piga M.

Minerva Anestesiol. 1996 Jan-Feb;62(1-2):33-54. Review. Italian.

PMID:
8768022
20.

Cholinesterase inhibitors for dementia with Lewy bodies.

Wild R, Pettit T, Burns A.

Cochrane Database Syst Rev. 2003;(3):CD003672. Review.

PMID:
12917981

Supplemental Content

Support Center